VetPlus Calmex Plug-In Diffuser Starter Kit 40ml for Dogs & Cats | Rose, Lavender & Chamomile Essential Oil Blend | Calming & Anxiety Support for Separation, Noise & Stress Events

FOR ANIMAL USE ONLY — Use as directed by a veterinarian or as per label instructions. Calmex Diffuser is a veterinary nutraceutical aromatherapy calming device — not a veterinary medicine. Veterinary guidance is recommended for animals with severe anxiety, aggression, compulsive disorders, or self-injurious behaviours; these require veterinary behavioural assessment and may require concurrent pharmacological intervention (anxiolytic medication: fluoxetine, clomipramine, trazodone, or gabapentin) alongside environmental and aromatherapy management. The Calmex Diffuser is intended for supportive use as part of a multimodal behaviour management plan — it is not a substitute for structured behavioural modification programmes (counterconditioning, desensitisation, systematic habituation) delivered by a qualified veterinary behaviourist or accredited clinical animal behaviourist. Ensure adequate room ventilation during diffuser use. Do not allow direct contact between the essential oil liquid and pet skin or mucous membranes. In homes with birds, use with caution — birds are particularly sensitive to airborne volatile organic compounds and essential oils due to their efficient unidirectional airflow lung and air sac respiratory system; consult a veterinarian before using any diffuser product in homes with pet birds. Keep the diffuser unit out of reach of animals and children. Replace the refill as directed and do not allow the unit to run dry.

VetPlus Calmex Plug-In Diffuser Starter Kit 40ml for Dogs & Cats | Rose, Lavender & Chamomile Essential Oil Blend | Calming & Anxiety Support for Separation, Noise & Stress Events

VetPlus Calmex Plug-In Diffuser Starter Kit is a veterinary aromatherapy calming device manufactured by VetPlus Ltd (UK) for use in homes with dogs and/or cats. The starter kit includes the plug-in diffuser unit and a 40ml essential oil refill. The diffuser continuously disperses a unique VetPlus-developed blend of three essential oils — Rosa damascena (Rose), Lavandula angustifolia (Lavender), and Matricaria recutita (German Chamomile) — as a fine aromatic vapour throughout the room, providing continuous environmental calming support. Refills (40ml) are available separately for ongoing use. The Calmex Diffuser is the environmental/room-based product in the Calmex calming range — complementary to the oral Calmex capsule and liquid products (which deliver L-theanine, pea protein hydrolysate, L-tryptophan, and B vitamins systemically) and can be used concurrently with oral Calmex for synergistic multimodal calming support.

The Neuroscience of Anxiety in Dogs & Cats: Why Environmental Calming Matters

• Fear and anxiety neuroanatomy — the amygdala-HPA axis fear circuit: fear and anxiety in companion animals are mediated by the basolateral amygdala (BLA) — the primary fear-conditioning structure of the brain’s limbic system; the BLA receives multimodal sensory input via the thalamus (fast thalamo-amygdala ‘low road’ for rapid pre-conscious threat detection) and the sensory cortex (slower cortical-amygdala ‘high road’ for conscious perceptual processing); fear conditioning occurs via LTP at glutamatergic BLA synapses (NMDA-dependent, CAMKII-mediated AMPA receptor phosphorylation); BLA outputs: CeA → PVN → CRH → ACTH → cortisol (HPA axis); CeA → locus coeruleus → noradrenaline (sympathetic arousal); CeA → PAG (defensive behaviours); the olfactory system has a privileged direct projection to the amygdala via olfactory bulb → piriform cortex → entorhinal cortex → amygdala, bypassing the thalamic relay required by all other sensory modalities — this direct olfactory-limbic connection is the neuroanatomical basis for aromatherapy’s ability to rapidly modulate emotional states
• Superior canine and feline olfactory system: dogs have approximately 300 million olfactory receptor neurons (vs 6 million in humans), approximately 811 functional OR genes, and approximately 170cm² of olfactory epithelium; cats have approximately 200 million ORNs and approximately 750 functional OR genes; both species have a well-developed vomeronasal organ (VNO — Jacobson’s organ) projecting via the accessory olfactory bulb → medial amygdala → hypothalamus for pheromone and conspecific chemical signalling; airborne essential oil molecules at concentrations imperceptible to humans are detected at high signal strength by dogs and cats, and the direct olfactory-limbic projection amplifies the CNS response to olfactory stimuli in companion animals

Active Essential Oils & Mechanisms of Action

• Rosa damascena (Damask Rose) essential oil — citronellol, geraniol, nerol & phenylethanol — GABAergic and serotonergic calming: principal components: citronellol (20–40%), geraniol (10–20%), nerol, and 2-phenylethanol (PEA); mechanisms: (a) GABA-A receptor positive allosteric modulation (PAM) — citronellol and geraniol potentiate GABA-A (the principal inhibitory CNS ionotropic Cl− channel, 2α+2β+1γ pentamer) at the benzodiazepine binding pocket (α/γ subunit interface) → increases Cl− channel open-state probability at submaximal GABA concentrations → net anxiolytic CNS inhibition; (b) 5-HT1A receptor partial agonism — geraniol and citronellol interact with 5-HT1A (Gi/o-coupled GPCR; same target as buspirone) in the raphe nucleus and limbic forebrain → anxiolytic effect without sedation; (c) 2-phenylethanol produces CNS depressant effects via GABA-A potentiation and possible TAAR1 agonism
• Lavandula angustifolia (True Lavender) essential oil — linalool & linalyl acetate — best-evidenced aromatherapy calming mechanism in companion animals: principal components: linalool (25–45%) and linalyl acetate (25–40%); mechanisms: (a) voltage-gated calcium channel (VGCC) inhibition — linalool inhibits N-type (CaV2.2) and P/Q-type (CaV2.1) VGCCs by blocking the S3-S4 voltage sensor domain → reduces presynaptic Ca2+ influx → reduces glutamate, substance P, and noradrenaline release at excitatory and stress-signalling synapses (same N/P/Q VGCC alpha-2-delta subunit mechanism as pregabalin and gabapentin, used clinically for noise phobia in dogs); (b) NMDA receptor antagonism — reduces glutamatergic excitation in the amygdala and hippocampus, reducing fear memory LTP formation and reconsolidation; (c) GABA-A PAM — linalool potentiates GABA-A at concentrations achieved by inhalation; (d) olfactory-specific mechanism — landmark studies demonstrated linalool’s anxiolytic effect was absent in anosmic (surgically bulbectomised) animals and absent when administered systemically — confirming the effect is mediated through the olfactory system rather than systemic absorption; veterinary evidence: Shepherd (JAVMA 2006) and Wells (AABS 2006) demonstrated lavender aromatherapy significantly reduced kennel stress behaviours (vocalisation, locomotion) and increased rest in kennelled dogs; Graham et al. (Physiol Behav 2005) showed lavender reduced travel-induced excitement in dogs
• Matricaria recutita (German Chamomile) essential oil — (−)-α-bisabolol, chamazulene & apigenin — 5-HT2A antagonism, 5-LOX inhibition, and GABA-A PAM: principal components: (−)-α-bisabolol (up to 50%), chamazulene (5–25%, the vivid blue azulene sesquiterpene formed from matricine during steam distillation); mechanisms: (a) (−)-α-bisabolol — 5-HT2A receptor antagonism (same mechanism as quetiapine and olanzapine — reduces amygdalar activation by reducing 5-HT2A-mediated glutamate release in the prefrontal cortex), GABA-A PAM (synergistic with linalool), and anti-inflammatory NF-κB inhibition (reducing neuroinflammatory IL-1β, IL-6, TNF-α); (b) chamazulene — potent 5-LOX inhibitor (reducing neuroinflammatory leukotriene LTB4 and CysLT1-mediated glutamatergic excitotoxicity in the amygdala) and azulene ring ROS quenching; (c) apigenin (4′,5,7-trihydroxyflavone) — partial agonist at the benzodiazepine site on GABA-A (Ki ∼4μM) → anxiolytic without sedation; the triple GABA-A PAM synergy of rose (citronellol/geraniol) + lavender (linalool) + chamomile (bisabolol/apigenin) via three independent binding sites on the GABA-A receptor complex provides additive and potentially synergistic anxiolytic activity

Clinical Indications

• Separation-related behaviours (separation anxiety) in dogs and cats — as part of a multimodal management plan including graduated departure training
• Noise phobias and sensitivities — fireworks, thunder, traffic, construction; begin use 1–2 days before anticipated noise events
• New environments — rehoming, new home introduction, boarding, kennelling, veterinary hospitalisation
• Multi-pet household conflict and inter-cat territorial tension
• Travel and veterinary visit preparation

Directions for Use

• Plug the diffuser unit into a standard electrical socket; insert the 40ml refill bottle per label instructions before plugging in
• Position at a low level in the room (diffusion occurs upward; low placement distributes aromatic vapour across the pet’s breathing zone)
• Allow 15–30 minutes for the aromatic environment to establish; use continuously in the animal’s primary living area for best results
• For noise events, begin at least 1–2 days before the anticipated event
• One 40ml refill provides approximately 4 weeks of continuous use; replace with Calmex Diffuser Refill 40ml (sold separately)
• Ensure the room is ventilated — keep a door or window slightly ajar; do not use in a fully sealed room

Safety Information

• For use in homes with dogs and cats; do not use in homes with birds or avian pets without veterinary guidance
• Do not allow direct contact between the diffuser unit or undiluted oil and animals or children
• Use in a ventilated room only — not in fully sealed or very small confined spaces
• For animals with severe anxiety or aggression, consult a veterinarian for a full multimodal behaviour management plan
• Store refills in a cool, dry place away from direct sunlight; essential oils degrade on UV exposure